X-Square Capital, LLC - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 33 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
X-Square Capital, LLC ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$34
+25.9%
17,743
-1.3%
0.02%
+33.3%
Q4 2022$27
-99.9%
17,9730.0%0.02%
-21.1%
Q3 2022$30,000
-16.7%
17,9730.0%0.02%
-13.6%
Q2 2022$36,000
-23.4%
17,9730.0%0.02%
-8.3%
Q1 2022$47,000
-6.0%
17,9730.0%0.02%
-4.0%
Q4 2021$50,000
-28.6%
17,9730.0%0.02%
-30.6%
Q3 2021$70,000
-48.5%
17,973
-14.3%
0.04%
-44.6%
Q2 2021$136,000
-21.4%
20,9730.0%0.06%
-18.8%
Q1 2021$173,00020,9730.08%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,518,371$9,746,0001.82%
Altium Capital Management LP 785,341$3,039,0000.80%
Ikarian Capital, LLC 2,691,110$10,415,0000.73%
Telemetry Investments, L.L.C. 130,500$505,0000.68%
Psagot Value Holdings Ltd. 143,591$556,0000.10%
Psagot Value Holdings Ltd. / (Israel) 143,591$556,0000.10%
ACT CAPITAL MANAGEMENT, LLC 28,500$110,0000.06%
X-Square Capital, LLC 17,973$70,0000.04%
GSA CAPITAL PARTNERS LLP 85,993$333,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 268,301$1,038,0000.03%
View complete list of TRACON PHARMACEUTICALS INC shareholders